WallStreetZenWallStreetZen

NASDAQ: TSHA
Taysha Gene Therapies Inc Stock Ownership - Who owns Taysha Gene Therapies?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Taysha Gene Therapies Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Sukumar NagendranPresident and Head of RD2025-09-1041,150$0.70
$28.76kBuy
Sukumar NagendranPresident and Head of RD2025-09-10200,000$3.23
$646.00kSell
Kamran AlamCHIEF FINANCIAL OFFICER2025-08-2154,491$2.85
$155.30kSell
Sukumar NagendranPresident and Head of RD2025-08-2157,054$2.85
$162.60kSell
Paul B. Manning10% Owner2025-05-30750,000$2.75
$2.06MBuy
Kamran AlamCHIEF FINANCIAL OFFICER2025-03-1129,843$1.69
$50.43kSell

1 of 1

TSHA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TSHA insiders and whales buy or sell their stock.

TSHA Shareholders

What type of owners hold Taysha Gene Therapies Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Rtw Investments LP9.17%25,021,584$124.11MInstitution
Ra Capital Management LP8.63%23,555,648$116.84MInstitution
Avoro Capital Advisors LLC7.95%21,700,000$107.63MInstitution
Morgan Stanley6.18%16,865,082$83.65MInstitution
Fmr LLC5.73%15,627,822$77.51MInstitution
Blackrock Inc4.88%13,303,775$65.99MInstitution
Octagon Capital Advisors LP4.62%12,592,500$62.46MInstitution
Goldman Sachs Group Inc4.61%12,587,700$62.43MInstitution
Siren LLC4.04%11,014,737$54.63MInstitution
Vanguard Group Inc3.99%10,894,127$54.03MInstitution

1 of 3

TSHA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TSHA89.44%10.56%Net BuyingNet Selling
NVAX62.75%17.11%Net Selling
ZYME53.28%46.72%Net BuyingNet Buying
ELVN49.50%50.50%Net SellingNet Selling
ZBIO64.89%35.11%Net BuyingNet Buying
View Top Biotech Stocks

Taysha Gene Therapies Stock Ownership FAQ

Who owns Taysha Gene Therapies?

Taysha Gene Therapies (NASDAQ: TSHA) is owned by 94.46% institutional shareholders, 11.15% Taysha Gene Therapies insiders, and 0.00% retail investors. Ra Session Ii is the largest individual Taysha Gene Therapies shareholder, owning 9.01M shares representing 3.30% of the company. Ra Session Ii's Taysha Gene Therapies shares are currently valued at $44.70M.

If you're new to stock investing, here's how to buy Taysha Gene Therapies stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.